negative regulation of chemokine-mediated signaling pathway

Definition

Target type: biologicalprocess

Any process that decreases the rate, frequency or extent of a chemokine-mediated signaling pathway. [GOC:mah]

Negative regulation of chemokine-mediated signaling pathways involves a complex interplay of cellular mechanisms that dampen or suppress the signaling cascade triggered by chemokines. Chemokines are small secreted proteins that act as chemoattractants, guiding the migration of immune cells to sites of inflammation or infection. This process begins with the binding of chemokines to their cognate G protein-coupled receptors (GPCRs) on the surface of target cells. Upon binding, the GPCRs undergo conformational changes, activating a signaling cascade involving various downstream proteins. However, excessive or uncontrolled chemokine signaling can lead to pathological conditions such as chronic inflammation and autoimmune diseases. Therefore, negative regulation is essential for maintaining immune homeostasis and preventing aberrant responses.

One major mechanism of negative regulation involves the desensitization of chemokine receptors. This process, also known as receptor internalization, involves the removal of activated GPCRs from the cell surface. Internalized receptors are either recycled back to the cell surface or degraded, effectively reducing the number of receptors available for chemokine binding. This downregulation of receptor expression limits the duration and intensity of chemokine signaling.

Another crucial component of negative regulation is the activation of inhibitory signaling pathways. These pathways often converge on the same downstream effector molecules as the stimulatory pathways, but they exert an opposite effect. For example, the activation of G protein-coupled receptor kinases (GRKs) can phosphorylate chemokine receptors, leading to the recruitment of arrestins. Arrestins are adaptor proteins that physically interact with GPCRs, blocking their interaction with G proteins and hindering further signaling.

Furthermore, negative regulation can occur at the level of chemokine production itself. Negative feedback loops can dampen chemokine expression by regulating the transcription or translation of chemokine genes. This feedback loop ensures that chemokine production is tightly controlled and does not become excessive. Additionally, chemokine antagonists can bind to chemokine receptors and block their interaction with chemokines, preventing the initiation of signaling pathways.

In summary, negative regulation of chemokine-mediated signaling pathways is a multi-faceted process that involves a combination of mechanisms, including receptor desensitization, activation of inhibitory pathways, and regulation of chemokine production. These mechanisms are essential for maintaining immune homeostasis and preventing excessive or aberrant responses to chemokines.'
"

Proteins (1)

Compounds (1)